ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,510,490 | +12.2% | 1,001,000 | +8.8% | 1.52% | +7.3% |
| Q2 2023 | $18,280,400 | +16.0% | 920,000 | 0.0% | 1.41% | +35.9% |
| Q1 2023 | $15,759,600 | -5.3% | 920,000 | +8.2% | 1.04% | +0.1% |
| Q4 2022 | $16,634,500 | +64.7% | 850,000 | +34.3% | 1.04% | +115.6% |
| Q3 2022 | $10,100,000 | +16.0% | 632,822 | 0.0% | 0.48% | +12.4% |
| Q2 2022 | $8,708,000 | -10.4% | 632,822 | +3.3% | 0.43% | -16.4% |
| Q1 2022 | $9,719,000 | -27.4% | 612,822 | 0.0% | 0.51% | -19.0% |
| Q4 2021 | $13,378,000 | -16.2% | 612,822 | +14.7% | 0.63% | -23.4% |
| Q3 2021 | $15,964,000 | – | 534,085 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 665,880 | $10,627,000 | 11.09% |
| RTW INVESTMENTS, LP | 15,802,802 | $252,213,000 | 5.82% |
| Ally Bridge Group (NY) LLC | 479,506 | $7,653,000 | 5.05% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,204,000 | 2.48% |
| TIGER MANAGEMENT L.L.C. | 279,700 | $4,464,000 | 1.95% |
| Prosight Management, LP | 200,000 | $3,192,000 | 1.71% |
| COWEN AND COMPANY, LLC | 999,588 | $15,953,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,398,000 | 1.32% |
| Affinity Asset Advisors, LLC | 267,794 | $4,274,000 | 1.19% |
| HARBOR CAPITAL ADVISORS, INC. | 66,410 | $1,060,000 | 0.97% |